The Innovator IBD 50 ETF (Ticker: FFTY) is a dynamic investment vehicle designed for those seeking exposure to high-potential growth stocks within the total market sphere. Nestled in the Size and Style category, this ETF distinctly focuses on capturing the essence of the broad-based market niche, making it a compelling choice for investors aiming to leverage market-wide opportunities with a strategic emphasis on growth.
FFTY is meticulously crafted to track the IBD 50 Index, a benchmark renowned for identifying 50 top-performing growth stocks exhibiting robust fundamental and technical characteristics. Investors can anticipate a portfolio that dynamically adapts to market trends, selecting companies that demonstrate superior earnings growth, strong sales, and leading market positions, often with a bias towards smaller-cap stocks that exhibit explosive growth potential.
With its unique approach, the Innovator IBD 50 ETF provides a concentrated yet diversified exposure, ideal for investors who are bullish on market-wide growth prospects but prefer a focused selection of top-performing equities. By blending comprehensive market coverage with a strategic focus on growth-centric stocks, FFTY stands out as a versatile instrument for those seeking to enhance their portfolios with a blend of innovative market leaders.
Asset Class
Equity
Region
North America
Issuer
Innovator
Index Tracked
IBD 50 TR
Ticker Symbol
FFTY
Innovator IBD 50 ETF (FFTY) Fund Flow Chart
Innovator IBD 50 ETF (FFTY) 1 year Net Flows: -$31M
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.